TY  - GEN
AU  - Bailon,P
AU  - Palleroni,A
AU  - Schaffer,C A
AU  - Spence,C L
AU  - Fung,W J
AU  - Porter,J E
AU  - Ehrlich,G K
AU  - Pan,W
AU  - Xu,Z X
AU  - Modi,M W
AU  - Farid,A
AU  - Berthold,W
AU  - Graves,M
TI  - Rational design of a potent, long-lasting form of interferon: a 40 kDa branched polyethylene glycol-conjugated interferon alpha-2a for the treatment of hepatitis C
SN  - 1043-1802
PY  - 2001///0816
KW  - Animals
KW  - Antineoplastic Agents
KW  - chemical synthesis
KW  - Antiviral Agents
KW  - Cell Line
KW  - Clinical Trials, Phase II as Topic
KW  - Clinical Trials, Phase III as Topic
KW  - Drug Design
KW  - Drug Screening Assays, Antitumor
KW  - Female
KW  - Hepatitis C
KW  - drug therapy
KW  - Humans
KW  - Immunoblotting
KW  - Interferon alpha-2
KW  - Interferon-alpha
KW  - Mice
KW  - Mice, Nude
KW  - Molecular Structure
KW  - Neoplasms
KW  - Polyethylene Glycols
KW  - Rats
KW  - Rats, Sprague-Dawley
KW  - Recombinant Proteins
KW  - Vesicular stomatitis Indiana virus
KW  - drug effects
N1  - Publication Type: Journal Article
UR  - https://doi.org/10.1021/bc000082g
ER  -